Fenamates and the potent inhibition of human liver phenol sulphotransferase

Xenobiotica

Volumn 30, Issue 2, 2000, Pages 111-116

  Vietri, M ^a   De Santi, C ^a   Pietrabissa, A ^a   Mosca, F ^a   Pacifici, G M ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL; ARYL SULFOTRANSFERASE; DOPAMINE; FLUFENAMIC ACID; MECLOFENAMIC ACID; MEFENAMIC ACID; NIFLUMIC ACID; TOLFENAMIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG INHIBITION; DRUG SELECTIVITY; DRUG SULFATION; DRUG TOXICITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; LIVER; XENOBIOTIC METABOLISM;

EID: 0034002230     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982500237712     Document Type: Article

References (20)

1. Anderson, R. J. and Weinshilboum, R. M., 1980, Phenolsulphotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clinica et Chimica Acta, 103, 79-90.
2. Anon., 1998, Drug Data Handbook, 3rd edn (Auckland: ADIS), pp. 6-48.
3. Bonham Carter, S. M., Rein, G., Glover, V. and Sandler, M., 1983, Human platelet phenolsulphotransferase M and P: substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide. British Journal of Clinical Pharmacology, 15, 323-330.
4. Bonnar, J. and Sheppard, B. L., 1996, Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. British Medical Journal, 313, 579-582.
5. Campbell, N. R. C., Van Loon, J. A. and Weinshilboum, R. M., 1987, Human liver phenol sulphotransferase: assay conditions, biochemical properties and partial purification of isoenzymes of the thermostable form. Biochemical Pharmacology, 36, 1435-1446.
6. Cappiello, M., Giuliani, L. and Pacifici, G. M., 1990, Differential distribution of phenol and catechol sulphotransferase in human liver and intestinal mucosa. Pharmacology, 40, 69-76.
7. Conroy, M. C., Randinitis, E. J. and Turner, J. L., 1991, Pharmacology, pharmacokinetics, and therapeutic use of meclofenamate sodium. Clinical Journal of Pain, 7 (suppl. 1), S44-48.
8. Foldes, A. and Meek, J., 1973, Rat brain phenolsulphotransferase-partial purification and some properties. Biochimica et Biophysica Acta, 327, 365-374.
9. Houin, G., Tremblay, D., Bree, F., Dufour, A., Ledudal, P. and Tillement, J. P., 1983, The pharmacokinetics and availability of niflumic acid in humans. International Journal of Clinical Pharmacology, Therapy and Toxicology, 21, 130-134.
10. Insel, P.A., 1996, Analgesic-antipyretic and antiinflammatory agents and drug employed in the treatment of gout. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon and A. Goodman Gilman (eds), The Pharmacological Basis of Therapeutics, 9th edn (New York: McGraw-Hill), pp. 617-659.
11. Lentjes, E. G. and Van Ginneken, C. A., 1987, Pharmacokinetics of flufenamic acid in man. International Journal of Pharmacology, Therapy and Toxicology, 25, 185-187.
12. Lowry, O. H., Rosebrough, N. J., Farr, A. and Randall, R. J., 1951, Protein measurement with Folin phenol reagent. Journal Biological Chemistry, 193, 265-275.
13. Mulder, G. J. and Jakoby, W. B., 1990, Sulfation. In G. J. Mulder (ed.), Conjugation Reactions in Drug Metabolism (New York: Taylor & Francis), pp. 107-161.
14. Neuvonen, P. J. and Kivisto, K. T., 1988, Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. European Journal of Clinical Pharmacology, 35, 495-501.
15. Pacifici, G. M. and De Santi, C., 1995, Human sulphotransferase. Classification and metabolic profile of the major isoforms. The point of view of the clinical pharmacologist. In G. M. Pacifici and G. N. Fracchia (eds), Advances in Drug Metabolism in Man (Luxembourg: European Commission), pp. 311-349.
16. Pacifici, G. M. and Viani, A., 1992, Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clinical Pharmacokinetics, 23, 449-468.
17. Raftogianis, R. B., Her, C. and Weinshilboum, R. M., 1996, Human phenol sulphotransferase pharmacogenetics: STP1* gene cloning and structural characterisation. Pharmacogenetics, 6, 473-487.
18. Weinshilboum, R. M., 1986, Phenol sulphotransferase in humans: properties, regulation, and function. Federation Proceedings, 45, 2223-2228.
19. Weinshilboum, R. M. and Otterness, D.M., 1994, Sulfotransferase enzymes. In: F. C. Kauffman (ed.), Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity. Handbook of Experimental Pharmacology Series, Volume 112 (Berlin: Springer), pp. 45-78.
20. Zhang, W. Y. and Li Wan Po, A., 1998, Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. British Journal of Obstetrics and Gynaecology, 105, 780-789.